Jiangsu Hualv Biological Technology Co.Ltd. (300970) — Cash Flow Reinvestment Rate
Jiangsu Hualv Biological Technology Co.Ltd. (300970) has a Cash Flow Reinvestment Rate of 0.36x as of December 2025, reinvesting CN¥123.12 Million (capex CN¥123.12 Million ) from operating cash flow of CN¥345.31 Million. Explore Jiangsu Hualv Biological Technology Co.L capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Hualv Biological Technology Co.Ltd. Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Jiangsu Hualv Biological Technology Co.Ltd. across 7 annual periods. Also explore balance sheet size of Jiangsu Hualv Biological Technology Co.L for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Jiangsu Hualv Biological Technology Co.Ltd. (2019–2025)
Year-by-year capital reinvestment analysis for Jiangsu Hualv Biological Technology Co.Ltd.. For live market cap and broader valuation context, see 300970 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.36x | CN¥123.12 Million | CN¥345.31 Million | CN¥123.12 Million | ▼ -90.8% |
| 2024 | 3.89x | CN¥536.45 Million | CN¥137.80 Million | CN¥268.22 Million | ▲ +100.0% |
| 2023 | 1.95x | CN¥324.39 Million | CN¥166.67 Million | CN¥224.15 Million | ▼ -15.3% |
| 2022 | 2.30x | CN¥413.20 Million | CN¥179.84 Million | CN¥407.91 Million | ▼ -77.5% |
| 2021 | 10.20x | CN¥847.81 Million | CN¥83.08 Million | CN¥204.09 Million | ▲ +487.3% |
| 2020 | 1.74x | CN¥345.91 Million | CN¥199.09 Million | CN¥190.96 Million | ▲ +39.1% |
| 2019 | 1.25x | CN¥267.34 Million | CN¥213.96 Million | CN¥98.54 Million | — |